Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery of small molecule, tumor-agnostic therapies. Black Diamond targets undrugged mutations in patients with genetically defined cancers. Black Diamond
There are no recent dividends present for BDTX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.